首页> 外国专利> NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS

NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS

机译:用于诊断肝纤维化的非侵入性方法

摘要

The invention relates to a method comprising a) providing a blood sample from a subject b) determining the level of CPS-1 expression in said sample c) comparing the level of CPS-1 expression of (b) to the level of CPS-1 expression determined from a blood sample from a subject with mild to moderate fibrosis of the liver d) determining the level of glutamate in said sample e) comparing the level of glutamate of (d) to level of glutamate determined from a blood sample from a subject with mild to moderate fibrosis of the liver f) wherein if the level of glutamate of (d) and CPS-1 expression of (b) is higher than the level of glutamate and CPS-1 expression from a blood sample from a subject with mild to moderate fibrosis of the liver, it is inferred the subject has increased likelihood of having advanced or severe (F3/F4) fibrosis of the liver.
机译:本发明涉及一种方法,该方法包括a)从受试者b)提供血液样品b)确定所述样品c中的CPS-1表达水平)将(b)的CPS-1表达水平与CPS-1的水平进行比较。 从受试者的受试者的血液样品中测定的表达,肝脏d)测定所述样品e)中谷氨酸水平的水平,比较来自受试者血液样品测定的谷氨酸水平的谷氨酸水平 具有轻度至中等纤维化的肝脏f)其中,如果(d)的谷氨酸水平和(b)的表达水平高于谷氨酸和Cps-1的水平,从受到温和的受试者的血液样品 为了中度纤维化的肝脏,推断受试者增加了肝脏晚期或严重(F3 / F4)纤维化的可能性。

著录项

  • 公开/公告号WO2021191603A1

    专利类型

  • 公开/公告日2021-09-30

    原文格式PDF

  • 申请/专利权人 KINGS COLLEGE HOSPITAL NHS FOUNDATION TRUST;

    申请/专利号WO2021GB50714

  • 发明设计人 AJAZ SAIMA;

    申请日2021-03-24

  • 分类号G01N33/68;

  • 国家 GB

  • 入库时间 2024-06-14 22:09:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号